Heart & metabolic health

  • £100,000 funding call opens for women’s and cardiovascular health projects

    A £100,000 funding call has opened for women's and cardiovascular health projects across Wessex, with £50,000 available for each area. The scheme will support research, patient and public involvement and engagement (PPIE), workshops and other initiatives aimed at improving health outcomes in local communities. Most awards are expected to be below £5,000, although applications for [...]

  • US researchers awarded NIH funding for global maternal heart failure trial

    A global trial will test whether bromocriptine can reduce deaths and complications in women with pregnancy-related heart failure. The study focuses on peripartum cardiomyopathy (PPCM), a rare but life-threatening form of heart failure that develops towards the end of pregnancy or within five months of childbirth. The placebo-controlled trial will enrol approximately 650 women to [...]

  • WHO launches global roadmap to tackle hypertension in pregnancy

    The World Health Organization (WHO) has launched a global roadmap to tackle hypertension in pregnancy and reduce deaths and serious illness among women and babies. The plan covers hypertensive disorders of pregnancy, including pre-eclampsia, which involve high blood pressure and can cause serious illness during pregnancy. These disorders affect an estimated 10 to 15 per [...]

  • Pregnancy complications linked to higher risk of cardiac and renal health conditions

    Pregnancy complications were linked to higher rates of heart, metabolic and kidney conditions in later years, a study of more than 1.4m women found. Complications in a woman’s latest or previous pregnancies were associated with increased rates of cardiovascular disease, type 2 diabetes, hypertension and chronic kidney disease. Gestational diabetes, high blood pressure during pregnancy [...]

  • GLP-1 prescriptions on rise among new mothers

    GLP-1 prescriptions among new mothers in the US rose sharply between 2018 and 2025, particularly among women with type 2 diabetes, new research has revealed. Researchers analysed private insurance claims covering just over one million births and tracked new prescriptions started within six months of giving birth. The proportion of postpartum women starting a GLP-1 [...]

  • RISE @ ESC Congress 2026: Building a future where every woman in cardiology can lead

    By Women As One Growing and thriving as a woman leader in cardiology was the central theme at RISE @ ESC Congress 2026 in Munich, Germany. Master of Ceremonies, Dr Julia Lueg, cardiologist at the Deutsches Herzzentrum der Charité, Berlin, welcomed hundreds of women in cardiology and their allies from around the world to connect, [...]

  • Sponsorship vs mentorship: Why both matter for career acceleration

    By Women As One Women receive advice. Men receive advocacy. If we want to close the gender gap, it’s time to be intentional about sponsorship. Building a career in cardiology takes more than hard work; it requires access, visibility, and support. One of the first pieces of career advice physicians receive is to find a [...]

  • In Europe, women are less likely to develop cardiovascular disease — but more likely to die from it

    By Women As One Cardiovascular disease remains the leading cause of death across European Society of Cardiology (ESC) member countries. Yet the latest 2025 ESC Atlas project report tells a story of progress. Over the past three decades, cardiovascular disease incidence and mortality rates have declined, reflecting advances in prevention, diagnosis, treatment, and healthcare delivery. [...]

  • Charity launches Women’s Health Plan to tackle inequalities in long-term conditions

     Chest Heart & Stroke Scotland has launched a three-year Women’s Health Plan setting out actions to improve prevention, diagnosis, treatment and support for women in Scotland. The 2026 to 2029 plan includes commitments on health information, prevention and early detection, professional training, peer support, post-diagnosis care, policy and research. It comes amid disparities affecting women [...]

  • Weight loss surgery improves menstrual health and PMOS symptoms, study finds

    Weight loss surgery was linked to more regular periods and fewer polyendocrine metabolic ovarian syndrome (PMOS) symptoms in women aged 18 to 45 living with obesity in a recent study. The researchers recommend that women undergoing the procedure have access to preconception care and reproductive counselling to support their reproductive health. Researchers at [...]